BIAFW — BIOAFFINITY TECHNOLOGIES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 3 SEC-registered investment managers reported holding BIAFW (BIOAFFINITY TECHNOLOGIES INC) in their latest 13F filings, with a combined reported value of $39.81K across 124.42K shares. That is +10.5% by share count (+11.87K shares) versus the previous quarter, while reported value moved +153.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of BIOAFFINITY TECHNOLOGIES INC (BIAFW) include ARMISTICE CAPITAL, LLC, Clear Street Group Inc., UBS Group AG, ranked by reported 13F value among the 7 institutional holders on this page.
BIAFW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 3 | 124.42K | $39.81K | +10.5% |
| Q2 2026 | 4 | 129.71K | $18.10K | -1.7% |
| Q1 2026 | 4 | 131.90K | $55.93K | -3.4% |
| Q4 2025 | 3 | 125.09K | $43.31K | -6.4% |
| Q3 2025 | 3 | 133.57K | $47.14K | -3.3% |
| Q2 2025 | 3 | 285.01K | $37.05K | -1.2% |
| Q1 2025 | 3 | 288.35K | $54.76K | +13.1% |
| Q4 2024 | 4 | 257.44K | $86.65K | +4.6% |
Over the 8 quarters shown, institutional share counts decreased 52% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+13.1%).
Top Institutional Holders (Q3 2026) — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 54.83K | $17.54K | 0.00% | Hold | |
| 48.23K | $15.43K | 0.00% | Add | |
| 21.37K | $6.84K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 54.93K | $7.66K | 0.00% | Hold | |
| 46.45K | $6.50K | 0.00% | Add | |
| 17.16K | $2.39K | 0.00% | Reduce | |
| 11.18K | $1.55K | 0.00% | Add |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 54.93K | $24.85K | 0.00% | Hold | |
| 46.11K | $20.89K | 0.00% | Reduce | |
| 19.85K | $6.55K | 0.00% | Reduce | |
| 11.01K | $3.63K | 0.00% | New |
Q4 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 55.04K | $19.26K | 0.00% | Reduce | |
| 46.55K | $16.29K | 0.00% | Reduce | |
| 23.50K | $7.75K | 0.00% | Reduce |
Q3 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 55.32K | $18.26K | 0.00% | New | |
| 47.67K | $15.73K | 0.00% | Reduce | |
| 30.58K | $13.15K | 0.00% | Reduce |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 204.08K | $26.53K | 0.00% | Hold | |
| 48.57K | $6.31K | 0.00% | Add | |
| 32.35K | $4.21K | 0.00% | Reduce |
New Positions (Q3 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Citadel Advisors sold 17.16K sh · $2.39K
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clear Street Group Inc. | 54.83K | 54.93K | 54.93K | 55.04K | 55.32K | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 48.23K | 46.45K | 46.11K | 46.55K | 47.67K | 48.57K | 48.28K | 665 | 467 | — | — | — | — | 285 | — | 66 | 11.71K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21.37K | 11.18K | 11.01K | — | — | — | — | — | — | — | — | — | 10.53K | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | 204.08K | 204.08K | 204.08K | 204.08K | 204.08K | 204.08K | 204.08K | 204.08K | — | — | — | — |
| Citadel Advisors | — | 17.16K | 19.85K | 23.50K | 30.58K | 32.35K | 35.99K | 50.24K | 39.18K | 22.22K | 24.18K | 24.38K | 25.72K | 28.54K | 15.24K | — | — |
| Warberg Asset Management LLC | — | — | — | — | — | — | — | — | — | 14.48K | 15.68K | 22.93K | 22.93K | — | — | — | — |
| OARSMAN CAPITAL, INC. | — | — | — | — | — | — | — | 2.45K | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold BIAFW?
As of 2026-Q3, 3 institutional funds reported holding BIAFW (BIOAFFINITY TECHNOLOGIES INC) in SEC 13F filings, with a combined reported value of $39.81K.
How many shares of BIAFW do institutions own?
13F filers reported 124.42K shares of BIAFW, worth $39.81K in aggregate at the end of 2026-Q3.
Is institutional ownership of BIAFW rising or falling?
Share counts moved +10.5% versus the prior quarter — accumulation.
Who are the top institutional holders of BIAFW?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Warberg Asset Management LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of BIOAFFINITY TECHNOLOGIES INC?
The major shareholders of BIOAFFINITY TECHNOLOGIES INC (BIAFW) by reported 13F value are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Warberg Asset Management LLC, among 7 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.